Uploaded November 2026 | Updated November 2026, 5 hours ago
One click. One shot. Medications helping millions of Americans lose weight.
But one wrong dose can make you dangerously sick.
As drugs like Ozempic, Wegovy, Mounjaro and Zepbound become more popular, the Indiana Poison Center is seeing a growing number of calls involving people taking these medications incorrectly.
And doctors warn that once someone takes too much, there is no quick fix.
“Once you’ve taken too much of it, there’s, you know, no antidote, no way to get it out of your system,” said Dr. Mary Wermuth, an IU Health medical toxicologist and assistant medical director of the Indiana Poison Center.
The numbers show a troubling trend.
In 2024, the Indiana Poison Center received 161 calls involving GLP-1 medications. That number nearly doubled to 320 in 2025.
During just the first six months of 2026, the center had already received 175 calls.
And 85% of those cases involved therapeutic errors — mistakes people made while using their medications.
Those errors include taking too much medication, accidentally giving themselves an extra dose or taking a drug daily when it is supposed to be taken weekly.
Wermuth says taking more than prescribed increases the risk of serious side effects.
“if you’re taking too much of it, then you have an increased chance of having some of these side effects.”
The medications are generally taken through injections. In fact, 72% of the cases reported to the Indiana Poison Center involved injections.
But how those injections are prepared can make a difference.
Clinical pharmacist Kelly Peddy demonstrated how the medications are administered and where patients can run into trouble.
Some FDA-approved GLP-1 medications come in prefilled injection pens, which simplify measuring the medication. Depending on the product, patients may need to select their dose or use a pen containing a preset amount.
Compounded versions, however, are often supplied in vials. Patients must draw the medication into a syringe and measure the correct amount themselves.
That’s where confusion can turn dangerous.
“There's a lot more room for dosing error with the compounded medications,” Peddy said.
A prescription may list a dose in milligrams, while the syringe measures milliliters or units. Confusing those measurements can lead someone to inject far more medication than prescribed.
The concentration of compounded medications can also vary, making it especially important for patients to understand exactly how much to draw into the syringe.
And the mistakes aren’t limited to measuring medication. Patients can also run into problems when increasing their dose too quickly or misunderstanding when to take their next injection.
The consequences can be painful.
Too much of these medications can trigger severe nausea, vomiting, diarrhea and abdominal pain.
Those symptoms can lead to dehydration, especially when someone cannot keep enough fluids down.
“They feel dizzy, they feel lightheaded, they’re not able to take in adequate oral fluids or eat food, then that is somebody that we would be worried about,” Wermuth said.
For some patients, the consequences can be even more serious.
“Sometimes these cases can be so severe that patients end up in the emergency room or in the hospital,” Peddy said.
Doctors are particularly concerned about older adults and people with underlying health conditions, including kidney disease. Severe dehydration can create additional complications for those patients.
People with diabetes who take insulin or certain other blood-sugar-lowering medications can also face a greater risk of dangerously low blood sugar.
Other serious complications associated with GLP-1 medications include pancreatitis and gallbladder problems.
Still, not every dosing mistake results in a hospital visit.
According to the Indiana Poison Center, approximately 68% of reported cases were managed without a referral to a health care facility. Others required additional medical evaluation or were already receiving care.
The data also show that 77% of reported cases involved women, with adults ages 30 to 69 accounting for much of the call volume.
_________________
Stay up to date by following our social media:
WSBT 22 on Facebook: facebook.com/WSBTNews
WSBT 22 on X: twitter.com/WSBT
WSBT 22 on Instagram: instagram.com/wsbt
For more information, visit wsbt.com
Have a news tip? Send it directly to our newsroom: wsbtnews@wsbt.com
WSBT is an IN based station and a CBS Television affiliate owned and operated by Sinclair Broadcast Group. Sinclair, Inc. is one of the largest and most diversified television broadcasting companies in the country today. Sinclair owns and operates, programs or provides sales services to 163 television stations in 77 markets, after pending transactions. Sinclair's television group reaches approximately 38.7% of US television households and includes FOX, ABC, MyTV, CW, CBS, NBC, Univision and Azteca affiliates.
One click. One shot. Medications helping millions of Americans lose weight.
But one wrong dose can make you dangerously sick.
As drugs like Ozempic, Wegovy, Mounjaro and Zepbound become more popular, the Indiana Poison Center is seeing a growing number of calls involving people taking these medications incorrectly.
And doctors warn that once someone takes too much, there is no quick fix.
“Once you’ve taken too much of it, there’s, you know, no antidote, no way to get it out of your system,” said Dr. Mary Wermuth, an IU Health medical toxicologist and assistant medical director of the Indiana Poison Center.
The numbers show a troubling trend.
In 2024, the Indiana Poison Center received 161 calls involving GLP-1 medications. That number nearly doubled to 320 in 2025.
During just the first six months of 2026, the center had already received 175 calls.
And 85% of those cases involved therapeutic errors — mistakes people made while using their medications.
Those errors include taking too much medication, accidentally giving themselves an extra dose or taking a drug daily when it is supposed to be taken weekly.
Wermuth says taking more than prescribed increases the risk of serious side effects.
“if you’re taking too much of it, then you have an increased chance of having some of these side effects.”
The medications are generally taken through injections. In fact, 72% of the cases reported to the Indiana Poison Center involved injections.
But how those injections are prepared can make a difference.
Clinical pharmacist Kelly Peddy demonstrated how the medications are administered and where patients can run into trouble.
Some FDA-approved GLP-1 medications come in prefilled injection pens, which simplify measuring the medication. Depending on the product, patients may need to select their dose or use a pen containing a preset amount.
Compounded versions, however, are often supplied in vials. Patients must draw the medication into a syringe and measure the correct amount themselves.
That’s where confusion can turn dangerous.
“There's a lot more room for dosing error with the compounded medications,” Peddy said.
A prescription may list a dose in milligrams, while the syringe measures milliliters or units. Confusing those measurements can lead someone to inject far more medication than prescribed.
The concentration of compounded medications can also vary, making it especially important for patients to understand exactly how much to draw into the syringe.
And the mistakes aren’t limited to measuring medication. Patients can also run into problems when increasing their dose too quickly or misunderstanding when to take their next injection.
The consequences can be painful.
Too much of these medications can trigger severe nausea, vomiting, diarrhea and abdominal pain.
Those symptoms can lead to dehydration, especially when someone cannot keep enough fluids down.
“They feel dizzy, they feel lightheaded, they’re not able to take in adequate oral fluids or eat food, then that is somebody that we would be worried about,” Wermuth said.
For some patients, the consequences can be even more serious.
“Sometimes these cases can be so severe that patients end up in the emergency room or in the hospital,” Peddy said.
Doctors are particularly concerned about older adults and people with underlying health conditions, including kidney disease. Severe dehydration can create additional complications for those patients.
People with diabetes who take insulin or certain other blood-sugar-lowering medications can also face a greater risk of dangerously low blood sugar.
Other serious complications associated with GLP-1 medications include pancreatitis and gallbladder problems.
Still, not every dosing mistake results in a hospital visit.
According to the Indiana Poison Center, approximately 68% of reported cases were managed without a referral to a health care facility. Others required additional medical evaluation or were already receiving care.
The data also show that 77% of reported cases involved women, with adults ages 30 to 69 accounting for much of the call volume.
_________________
Stay up to date by following our social media:
WSBT 22 on Facebook: facebook.com/WSBTNews
WSBT 22 on X: twitter.com/WSBT
WSBT 22 on Instagram: instagram.com/wsbt
For more information, visit wsbt.com
Have a news tip? Send it directly to our newsroom: wsbtnews@wsbt.com
WSBT is an IN based station and a CBS Television affiliate owned and operated by Sinclair Broadcast Group. Sinclair, Inc. is one of the largest and most diversified television broadcasting companies in the country today. Sinclair owns and operates, programs or provides sales services to 163 television stations in 77 markets, after pending transactions. Sinclair's television group reaches approximately 38.7% of US television households and includes FOX, ABC, MyTV, CW, CBS, NBC, Univision and Azteca affiliates.



![Elkhart Fire Department uses new device with AI to help locate victims in water
Every minute counts in a water rescue.
Now, a new device is helping first responders search underwater more quickly.
The Elkhart Fire Department is among the few departments that are using this new technology called AquaEye.
This technology could take valuable minutes off these searches.
The device uses AI technology to help locate potential victims in the water. It scans up to a football field in length and more than a hundred feet deep. In combination with sonar it locates within seconds where the potential victim could be.
The device marks the possible location of a person on a map. Other objects, like submerged vehicles, appear differently.
“So, with this we just show up, we do a scan and then it shows right on there, exactly how many feet they are weighing everything. So, I mean it goes from hours to minutes,” said Jason Gour, Elkhart Fire Division Chief of Operations.
Crews are then able to determine exactly how many feet out from the shore the person could be and guide rescue divers to that spot.
“We have about a mile of square footage of water in the Elkhart area, and its important that with our two rivers,[we know] how deep they are, as well as how the rapid flow of the stream; that we have the opportunity to go straight to a victim and or an object and be able to locate it, said Mayor Rod Roberson (D), Elkhart.
The addition of AquaEye may replace the traditional underwater sweep method, where divers rely on touch and often have limited visibility.
Crews want to be prepared and stay ahead with new technology.
“There obviously there have been incidents in the area over the last couple of years that have happened. And we have areas of water such as this, such as the Elkhart St. Joe River and things like that to kind of be proactive and trying to be on the cutting edge of the technology versus waiting,” said Gour.
The city hopes AquaEye can help crews respond faster, better understand what they’re searching for and ultimately save more lives.
“I just think that its important for us to be able to operate quickly. Its important for us to be able to know what were diving for. And its important for us to have the right equipment to act when you find that object,” said Roberson.
Elkhart Fire Crews have spent the past few months training with AquaEye.
The department says it’s ready to assist neighboring communities with the technology when needed.
Stay up to date by following our social media:
WSBT 22 on Facebook: https://www.facebook.com/WSBTNews
WSBT 22 on X: https://twitter.com/WSBT
WSBT 22 on Instagram: https://www.instagram.com/wsbt/
For more information, visit https://wsbt.com/
Have a news tip? Send it directly to our newsroom: wsbtnews@wsbt.com
WSBT is an IN based station and a CBS Television affiliate owned and operated by Sinclair Broadcast Group. Sinclair, Inc. is one of the largest and most diversified television broadcasting companies in the country today. Sinclair owns and operates, programs or provides sales services to 163 television stations in 77 markets, after pending transactions. Sinclairs television group reaches approximately 38.7% of US television households and includes FOX, ABC, MyTV, CW, CBS, NBC, Univision and Azteca affiliates. Elkhart Fire Department uses new device with AI to help locate victims in water](https://i.ytimg.com/vi/uIluGhgbKL8/mqdefault.jpg)
![Election 2026: Abdul El-Sayed defeats Mike Rogers for Michigan Senate seat
Abdul El-Sayed celebrated a major victory in Michigans U.S. Senate race, defeating Republican Mike Rogers in one of the most closely watched contests of the election.
El-Sayed defeated former Congressman Mike Rogers 52% to 45%, and will become the first Muslim American to serve in the chamber.
El-Sayed celebrated the victory with a pointed message for President Trump and Vice President JD Vance.
He says Vance will have to swear him in when the new Senate takes office in January.
There is this delicious irony in the fact that youre [JD Vance] constitutionally obligated to swear me in in January. So you know what that means. Wolverines 1, Buckeyes 0. Donald, look, I know you struggled with my name, so after JD swears me in in January, you can just go on and call me Senator, said El-Sayed.
The race drew national attention, with a late endorsement of Rogers from El-Sayeds former Democratic primary opponent and Republicans attacking El-Sayed over his background and loyalties — claims he rejected throughout his campaign.
Rogers made El-Sayeds faith and national security a central focus of his campaign, questioning his ties to the Muslim Brotherhood and describing his policies as a radical Islamic agenda.
El-Sayed denied those allegations, and said Rogers was trying to distract from issues like the economy and healthcare.
The two also clashed over El-Sayeds criticism of U.S. support for Israel and his progressive policy proposals.
But El-Sayed won, turning the race into a major victory for Democrats, and a historic one for the Senate.
I want you to let them know that we, together, fighting for something bigger, we won. So Mike, enjoy your retirement . . . See, you chose hate, and Michigan chose hope. May we never have to see the likes of you in this state again, said El-Sayed.
El-Sayed will fill the seat being vacated by retiring Senator Gary Peters (D) in January.
https://wsbt.com/news/local/election-2026-michigan-senate-seat-plays-key-role-in-control-of-us-senate-democrat-abdul-el-sayed-republican-mike-rogers-campaigns-voters-voting-win-winner-washington-dc-endorsement
Stay up to date by following our social media:
WSBT 22 on Facebook: https://www.facebook.com/WSBTNews
WSBT 22 on X: https://twitter.com/WSBT
WSBT 22 on Instagram: https://www.instagram.com/wsbt/
For more information, visit https://wsbt.com/
Have a news tip? Send it directly to our newsroom: wsbtnews@wsbt.com
WSBT is an IN based station and a CBS Television affiliate owned and operated by Sinclair Broadcast Group. Sinclair, Inc. is one of the largest and most diversified television broadcasting companies in the country today. Sinclair owns and operates, programs or provides sales services to 163 television stations in 77 markets, after pending transactions. Sinclairs television group reaches approximately 38.7% of US television households and includes FOX, ABC, MyTV, CW, CBS, NBC, Univision and Azteca affiliates. Election 2026: Abdul El-Sayed defeats Mike Rogers for Michigan Senate seat](https://i.ytimg.com/vi/uSakTOfMm4M/mqdefault.jpg)





